Similar companies
Income Statement (USD)
| Q3 '25 | QoQ | |
|---|---|---|
| Operating expense | 46M | 11.7% |
| Net Income | -67M | 57.4% |
| EBITDA | -66M | 63.3% |
Balance Sheet (USD)
| Q3 '25 | QoQ | |
|---|---|---|
| Total Assets | 237M | 10.6% |
| Total Liabilities | 106M | 33.4% |
| Total Equity | 131M | 29.6% |
| Shares Outstanding | 86M | 0.6% |
Cash Flow (USD)
| Q3 '25 | QoQ | |
|---|---|---|
| Cash from operations | -30M | 0.1% |
| Cash from investing | 15M | 139% |
| Cash from financing | 750,000 | 96.2% |
EPS
Financial Highlights for Mind Medicine (MindMed) in Q3 '25
Operating Expenses for this period were 46M, showing a 11.7% change from the last quarter. Operating expenses cover the costs of running daily business operations. A significant increase might indicate inefficiencies or investments in growth, while a decrease could suggest cost-saving measures or potential underinvestment in key areas.
Net Income for the quarter was -67M, showing a -57.4% change from the prior quarter. Net income provides a clear picture of the company's profitability after all expenses. An increase suggests the company is becoming more profitable, while a decrease may raise concerns about the company's financial health, unless there are specific one-time costs or investments.
The company's EBITDA for the quarter was -66M, showing a -63.3% change from the previous period. EBITDA gives insight into the company's operational profitability, excluding non-operating expenses like interest and taxes. A rising EBITDA indicates strong operational performance, while a declining EBITDA may signal operational challenges or increased costs.
Mind Medicine (MindMed) faced some challenges this quarter with a decline in one or more of the key metrics: revenue, gross profit, or net income. Higher operating expenses might indicate increased investments or potential inefficiencies. A decline in EBITDA signals potential operational challenges or increased costs.
